PortfoliosLab logo
BNTX vs. MOH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BNTX and MOH is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

BNTX vs. MOH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioNTech SE (BNTX) and Molina Healthcare, Inc. (MOH). The values are adjusted to include any dividend payments, if applicable.

200.00%400.00%600.00%800.00%December2025FebruaryMarchAprilMay
574.40%
188.24%
BNTX
MOH

Key characteristics

Sharpe Ratio

BNTX:

0.10

MOH:

-0.12

Sortino Ratio

BNTX:

0.45

MOH:

0.16

Omega Ratio

BNTX:

1.05

MOH:

1.02

Calmar Ratio

BNTX:

0.02

MOH:

-0.14

Martin Ratio

BNTX:

0.11

MOH:

-0.38

Ulcer Index

BNTX:

14.24%

MOH:

13.32%

Daily Std Dev

BNTX:

52.92%

MOH:

44.86%

Max Drawdown

BNTX:

-82.25%

MOH:

-68.37%

Current Drawdown

BNTX:

-78.53%

MOH:

-22.33%

Fundamentals

Market Cap

BNTX:

$25.23B

MOH:

$17.32B

EPS

BNTX:

-$3.14

MOH:

$20.71

PEG Ratio

BNTX:

0.04

MOH:

-0.62

PS Ratio

BNTX:

9.17

MOH:

0.43

PB Ratio

BNTX:

1.15

MOH:

4.00

Total Revenue (TTM)

BNTX:

$2.73B

MOH:

$41.85B

Gross Profit (TTM)

BNTX:

$2.17B

MOH:

$4.78B

EBITDA (TTM)

BNTX:

-$76.89M

MOH:

$1.90B

Returns By Period

In the year-to-date period, BNTX achieves a -16.82% return, which is significantly lower than MOH's 11.96% return.


BNTX

YTD

-16.82%

1M

9.38%

6M

-12.14%

1Y

5.16%

5Y*

14.34%

10Y*

N/A

MOH

YTD

11.96%

1M

-1.45%

6M

-3.50%

1Y

-5.39%

5Y*

13.21%

10Y*

17.37%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BNTX vs. MOH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BNTX
The Risk-Adjusted Performance Rank of BNTX is 5252
Overall Rank
The Sharpe Ratio Rank of BNTX is 5656
Sharpe Ratio Rank
The Sortino Ratio Rank of BNTX is 5151
Sortino Ratio Rank
The Omega Ratio Rank of BNTX is 4949
Omega Ratio Rank
The Calmar Ratio Rank of BNTX is 5353
Calmar Ratio Rank
The Martin Ratio Rank of BNTX is 5353
Martin Ratio Rank

MOH
The Risk-Adjusted Performance Rank of MOH is 4343
Overall Rank
The Sharpe Ratio Rank of MOH is 4545
Sharpe Ratio Rank
The Sortino Ratio Rank of MOH is 4242
Sortino Ratio Rank
The Omega Ratio Rank of MOH is 4242
Omega Ratio Rank
The Calmar Ratio Rank of MOH is 4343
Calmar Ratio Rank
The Martin Ratio Rank of MOH is 4545
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BNTX vs. MOH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BioNTech SE (BNTX) and Molina Healthcare, Inc. (MOH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current BNTX Sharpe Ratio is 0.10, which is higher than the MOH Sharpe Ratio of -0.12. The chart below compares the historical Sharpe Ratios of BNTX and MOH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50December2025FebruaryMarchAprilMay
0.10
-0.12
BNTX
MOH

Dividends

BNTX vs. MOH - Dividend Comparison

Neither BNTX nor MOH has paid dividends to shareholders.


TTM202420232022
BNTX
BioNTech SE
0.00%0.00%0.00%1.41%
MOH
Molina Healthcare, Inc.
0.00%0.00%0.00%0.00%

Drawdowns

BNTX vs. MOH - Drawdown Comparison

The maximum BNTX drawdown since its inception was -82.25%, which is greater than MOH's maximum drawdown of -68.37%. Use the drawdown chart below to compare losses from any high point for BNTX and MOH. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%December2025FebruaryMarchAprilMay
-78.53%
-22.33%
BNTX
MOH

Volatility

BNTX vs. MOH - Volatility Comparison

BioNTech SE (BNTX) has a higher volatility of 25.24% compared to Molina Healthcare, Inc. (MOH) at 14.47%. This indicates that BNTX's price experiences larger fluctuations and is considered to be riskier than MOH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%December2025FebruaryMarchAprilMay
25.24%
14.47%
BNTX
MOH

Financials

BNTX vs. MOH - Financials Comparison

This section allows you to compare key financial metrics between BioNTech SE and Molina Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B20212022202320242025
182.80M
11.15B
(BNTX) Total Revenue
(MOH) Total Revenue
Values in USD except per share items